Association of β-amyloid peptide fragments with neuronal nitric oxide synthase: Implications in the etiology of Alzheimers disease

16Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Neuronal nitric oxide synthase (nNOS) was purified on DEAE-Sepharose anion-exchange in a 38% yield, with 3-fold recovery and specific activity of 5 mol.min-1.mg-1. The enzyme was a heterogeneous dimer of molecular mass 225kDa having a temperature and pH optima of 40°C and 6.5, Km and Vmax of 2.6 μM and 996 nmol.min-1.ml-1, respectively and was relatively stable at the optimum conditions (t 1/2=3h). β-Amyloid peptide fragments Aβ17-28 was the better inhibitor for nNOS (Ki=0.81 μM). After extended incubation of nNOS (96h) with each of the peptide fragments, Congo Red, turbidity and thioflavin-T assays detected the presence of soluble and insoluble fibrils that had formed at a rate of 5nM.min-1. A hydrophobic fragment Aβ17-21 [Leu17 - Val18 - Phe 19 -Phe20 -Ala21] and glycine zipper motifs within the peptide fragment Aβ17-35 were critical in binding and in fibrillogenesis confirming that nNOS was amyloidogenic catalyst. © 2012 Informa UK, Ltd.

Cite

CITATION STYLE

APA

Padayachee, E., Ngqwala, N., & Whiteley, C. G. (2012). Association of β-amyloid peptide fragments with neuronal nitric oxide synthase: Implications in the etiology of Alzheimers disease. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(3), 356–364. https://doi.org/10.3109/14756366.2011.590805

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free